Brought to you by 
Verastem completes $58.8mm IPO
03 Feb 2012
Executive Summary
Verastem Inc. (cancer therapeutics development) sold 6.3mm common shares (including the overallotment) at $10 each, netting $58.8mm in its initial public offering. The company originally filed in November 2011 planning to sell 4.5mm shares between $9-11.
Deal Industry
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Verastem completes $58.8mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice